NEW ADVANCES IN SEVERE ADVERSE DRUG RESCTIONS

Identifieur interne : 002267 ( Main/Exploration ); précédent : 002266; suivant : 002268

---

NEW ADVANCES IN SEVERE ADVERSE DRUG RESCTIONS

Auteurs : Jean Revuz [France]

Source :

• Dermatologic Clinics [ 0733-8635 ] ; 2001.

RBID : ISTEX:8F8F7877E7FD5555AF0F23AB2CA426BC569F7CFA

English descriptors

• Teeft :
  • Abnormal parameters, Adverse cutaneous reactions, Agep, Aids patients, Antibacterial agents, Anticonvulsant hypersensitivity syndrome, Apoptosis, Arch dermatol, Case reports, Clinical picture, Coll surg, Confidence interval, Consecutive patients, Contact dermatitis, Contact sensitization, Corticosteroid, Cutaneous, Cutaneous drug reactions, Cutaneous manifestations, Cutaneous reactions, Dermatitis, Dermatol, Dermatol venereol, Drug eruptions, Drug hypersenitivity syndrome, Drug interactions, Drug metabolism, Drug rash, Drug reaction, Drug reactions, Drug withdrawal, Early withdrawal, Eosinophilia, Epidermal, Epidermal detachment, Epidermal necrolysis, Epidermal necrosis, Eruption, Erythema, Erythema multiforme, Exanthematic, Exanthematic pustulosis, Exanthematous pustulosis, Exceptional cases, Exfoliative dermatitis, Herpes simplex, High doses, High fever, Human herpesvirus, Human immunoglobulins, Hypersensitivity, Hypersensitivity rash, Hypersensitivity syndrome, Idiopathic hypereosinophilic syndrome, Immune, Immune mechanisms, Immunodeficiency syndrome, Immunosuppressive drugs, Initial percentage, Intensive care, Keratinocyte death, Keratinocytes, Lesion, Maculopapular, Mechanical ventilation, Mortality rate, Mortality rates, Mucous membrane lesions, Necrolysis, Necrosis, Neutrophilic, Nicorandil, Odds ratio, Oral ulcers, Other drugs, Other hand, Peripheral blood, Pivotal role, Plasma exchange, Pneumocystis carinii pneumonia, Poor prognosis, Prognosis, Prognostic index, Psoriasis, Pustular, Pustular psoriasis, Pustule, Pustulosis, Rash, Responsible drug, Retrospective study, Risk factor, Roujeau, Scorten, Serum glucose, Several case reports, Several types, Severe cutaneous drug reactions, Severe drug reactions, Severe hypersensitivity syndrome, Skin detachment, Skin lesions, Steroid, Syndrome, Systemic, Systemic corticosteroids, Systemic steroids, Systemic symptoms, Thalidomide, Toxic, Toxic epidermal necrolysis, Tumor necrosis factor, Unpublished data, Viral infections, Visceral involvement, Visceral manifestations.

Url:

• https://api.istex.fr/ark:/67375/6H6-R2J9DTFR-P/fulltext.pdf

DOI: 10.1016/S0733-8635(05)70309-0

Affiliations:

• France

---

Links toward previous steps (curation, corpus...)

• to stream Istex, to step Corpus: 001F50
• to stream Istex, to step Curation: 001F50
• to stream Istex, to step Checkpoint: 001090
• to stream Main, to step Merge: 002291
• to stream Main, to step Curation: 002267

---

Le document en format XML

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002267 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002267 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:8F8F7877E7FD5555AF0F23AB2CA426BC569F7CFA
   |texte=   NEW ADVANCES IN SEVERE ADVERSE DRUG RESCTIONS
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021